SARS-CoV-2 Assay

The SARS-CoV-2 Assay is a real-time RT-PCR assay intended for the qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens (such as nasal, midturbinate, nasopharyngeal, and oropharyngeal swab specimens) from individuals suspected of COVID-19 by their healthcare provider.

Notify me on updates of this product 

Availability: Commercially Available

Dr. Amy L. Leber
Director, Clinical Microbiology and Immunoserology, Department of Laboratory Medicine
+1 614 722 2000
700 Children’s Drive, Bldg H, Rm H-LL D00620
Columbus, OH 43205
USA
www.nationwidechildrens.org
Manufacturer
Nationwide Children's Hospital
Product Name
SARS-CoV-2 Assay
Detection Category
Biological
Detection Principle
Molecular;
Detection Method
Assays;Nucleic Acid Amplification;
Application
Diagnostics;
Equipment Type
Diagnostic
Product Synopsis
The SARS-CoV-2 Assay is a real-time RT-PCR assay intended for the qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens (such as nasal, midturbinate, nasopharyngeal, and oropharyngeal swab specimens) from individuals suspected of COVID-19 by their healthcare provider.
Availability
Commercially Available
Technology Readiness Level (TRL)
9
Market Entry Date
April 2020
User Feedback Sources
Indifferent/No user feedback
No Information Is Available
Transportability
Pocket Size
Other Biological Targets
SARS-CoV-2
Training Required
<1 day training
Please enter contact info.
Email Address: 
Company: 
Name: 
Title: